Pfizer said U.S. regulators have approved its acquisition of smaller rival Hospira, pending the divestiture of some sterile injectable drugs, putting the deal on track to close in early September.
from WSJ.com: US Business http://ift.tt/1h8Klet
via IFTTT
No comments:
Post a Comment